Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Christine Xu, Ph.D
Sr Director
Sanofi
Poster(s):
(M-123) Streamlining Dupilumab Nasal Polyposis Clinical Development Strategy: Leveraging Modeling and Biomarker Bridging for the Phase 3 Dose Selection
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST
(M-124) Physiologically-based pharmacokinetic modeling approach to support eliglustat development for pediatric patients with Gaucher disease
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST
